Document is current
Any future updates will be listed below
-
Authors
Pilotto, Andrea
Pelucchi, Silvia
Trasciatti, Chiara
Ferullo, Lucia
Poli, Loris
Tolassi, Chiara
Catanese, Alberto
Girotto, Irene
Labella, Beatrice
Gorla, Federica
D’Andrea, Laura
Stringhi, Ramona
Di Luca, Monica
Marcello, Elena
Padovani, Alessandro
-
Funding
Funding for this research was provided by:
Ministero dell’Università e della Ricerca (2017MYJ5TH)
Innovative Medicines Initiative (ID853981)
Ministero della Salute (PNRR-MAD-2022-12376110)
Airalzh Foundation (AGYR2021 Life-Bio)
LIMPE-DISMOV Foundation Segala Grant 2021
DIGI-BRAIN the H2020 IMI IDEA-FAST (ID853981)
Ministero dell’Istruzione, dell’Università e della Ricerca (RF-2018-12366209)
Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 20202THZAW)
Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN202039WMFP)
Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN COCOON (2017MYJ5TH))
Michael J. Fox Foundation for Parkinson’s Research (022343)
National Recovery and Resilience Plan
MNESYS (PE0000006)
MNESYS (PE0000006)
Piano di Sostegno alla Ricerca, Università degli Studi di Milano (PSR2023_SPELU)
LifeArc
Karin Christiane Conradi Stiftungsfonds
Deutsche Gesellschaft für Muskelkranke
Frick-Foundation for ALS research
Deutsche Forschungsgemeinschaft (CA 2915/4-1)
Fondo Italiano per la Scienza (FIS00000560)
Giovanni Armenise-Harvard Foundation
Associazione Italiana Ricerca Alzheimer
H2020 IMI IDEA-FAST (ID853981)
NextGenerationEU (NRRP M6C2)
- License Information
-
More Information
Article History
Received: 23 October 2025
Accepted: 4 February 2026
First Online: 16 February 2026
Declarations
:
: Andrea Pilotto received consultancy/speaker fees from Abbvie, Angelini, Bial, Eli Lilly, Lundbeck, Roche and Zambon pharmaceuticals. He acts as consultant as part of advisory Board of Angelini Pharma and BIAL pharmaceutics. Silvia Pelucchi declares no conflict of interest. Chiara Trasciatti declares no conflict of interest. Lucia Ferullo declares no conflict of interest. Loris Poli declares no conflict of interest. Chiara Tolassi declares no conflict of interest. Alberto Catanese declares no conflict of interest. Irene Girotto declares no conflict of interest. Beatrice Labella declares no conflict of interest. Federica Gorla declares no conflict of interest. Laura D’Andrea declares no conflict of interest Ramona Stringhi declares no conflict of interest Monica di Luca received advisory board fees from Roche Elena Marcello received speaker fees from Eli Lilly and GE Healthcare, advisory board fees from Roche, teaching fees from Eisai Alessandro Padovani received personal compensation as a consultant/scientific advisory board member for Biogen, Eisai Eli Lilly, General Healthcare (GE), Lundbeck, Nestlè, Roche.
